HKEX is aiming to overtake New York’s Nasdaq when it comes to the number of Chinese biotech company listings and market capitalisation. Photo: Reuters

Ascentage Pharma is the latest mainland biotech firm to pick Hong Kong for fundraising

Company’s chairman says city is ‘new to the game’ and stakeholders will have plenty of ‘lessons to learn’

Topic |   IPO

TOP PICKS

HKEX is aiming to overtake New York’s Nasdaq when it comes to the number of Chinese biotech company listings and market capitalisation. Photo: Reuters
READ FULL ARTICLE